Merck Opens $1 Billion Vaccine Manufacturing Facility in North Carolina
Merck has opened a new $1 billion vaccine manufacturing facility in Durham, North Carolina147.
The 225,000-square-foot plant will produce bulk substance for Merck's HPV vaccine Gardasil17.
The facility features advanced technologies including data analytics, generative AI, 3D printing, and digital twin technology14.
Merck's Durham complex, occupied since 2004, also produces vaccines for chickenpox, measles, and rubella1.
The company manufactured over 70 million vaccine doses at the Durham site last year1.
Merck has invested more than $12 billion in expanding its US manufacturing and R&D capabilities since 201814.
The new facility is part of Merck's efforts to strengthen its production and manufacturing capabilities in the United States47.
The Durham campus now employs more than 1,000 people1.
Merck is also building a facility at the Durham site to expand production of its bladder cancer medication TICE BCG1.
The company reported $64.2 billion in global revenue in 2024, with $32.3 billion generated in the United States4.
Sources:
1. https://www.fiercepharma.com/manufacturing/merck-opens-1b-vaccine-manufacturing-facility-north-carolina
4. https://spectrumlocalnews.com/nc/triad/news/2025/03/11/merk-opens-new--1-billion-durham-vaccine-manufacturing-facility-
7. https://abc11.com/post/drugmaker-merck-opens-new-vaccine-manufacturing-facility-north-durham/16007474/